Articles that mention Gilead Sciences -BoardProspects

Gilead Sciences

0 Comments Leave a Comment

1-15 of 19 1 2 »
1. Mentioned In 19 Articles
2. Neurocrine Biosciences Announces Appointment of Johanna Mercier to Board of Directors
  
  Explore PR Newswire Apr 17 2021 BoardMoves
  
  ... the appointment of Johanna Mercier to its Board of Directors. Ms. Mercier is the Chief Commercial Officer of Gilead Sciences, with responsibility for the global commercialization of Gilead's medicines... ...
  Read Full Article
  
  Comment
  
  Mentions: Nasdaq Gilead Sciences Board
3. Astra Plots Post-Covid Future With $39 Billion Alexion Deal
  
  Explore msn.com Dec 12 2020 BoardNews
  
  ...at Soriot fended off six years ago taught the importance of scale. AstraZeneca made a preliminary approach to Gilead Sciences Inc., Bloomberg reported in June. While those talks went no further, adding Alexion could put ...
  Read Full Article
  
  Comment
  
  Mentions: Management Goldman Sachs CFO
4. Jeffrey A. Bluestone Joins Gilead Sciences’ Board of Directors
  
  Explore Gilead Sciences, Inc. Dec 8 2020 BoardMoves
  
  ...FOSTER CITY, Calif.--(BUSINESS WIRE)--Gilead Sciences, Inc. (Nasdaq: GILD) announced today that Jeffrey A. Bluestone, PhD, has been appointed to the companys Board of Directors... ...
  Read Full Article
  
  Comment
  
  Mentions: Nasdaq Gilead Sciences Gilead Sciences, Inc.
5. Gilead Sold $873 Million Worth of its Antiviral COVID-19 Treatment Even Though Data on its Success Remains Mixed
  
  Explore Business Insider Oct 28 2020 BoardNews
  
  ... that has been validated with all of the rigor required for an FDA approval," Daniel O'Day, chairman & CEO of Gilead Sciences, said on the call. Gilead sales of Veklury could total $5.4 billion in 2020 and $8.5 billion i...
  Read Full Article
  
  Comment
  
  Mentions: Gilead Sciences Daniel O'Day Wall Street
6. Anthony Welters Joins Gilead Sciences’ Board of Directors
  
  Explore Investing News Network Oct 22 2020 BoardMoves
  
  ...Gilead Sciences, Inc. (Nasdaq:GILD) announced today that Anthony Welters has been appointed to the companys Board of Directors... ...
  Read Full Article
  
  Comment
  
  Mentions: Nasdaq Gilead Sciences Gilead Sciences, Inc.
7. 20 Highest-Paid Biopharma CEOs
  
  Explore Pharma News Sep 18 2020 BoardNews
  
  ...ages don't reflect a company's size. A few CEOs beat their companies onto the big money lists--John Martin at Gilead Sciences ($GILD), for one; he's been on our executive-pay list for several years, while Gilead joined t...
  Read Full Article
  
  Comment
  
  Mentions: Twitter stock options Vertex
8. Gilead Reaches $21 Billion Deal for Immunomedics
  
  Explore MarketWatch Sep 13 2020 BoardNews
  
  ...$88 a share in cash for Immunomedics, whose shares closed at $42.25 Friday. That represents a 108% premium... Gilead Sciences Inc. will pay $21 billion to buy biotech Immunomedics Inc. and its prized breast-cancer drug, ...
  Read Full Article
  
  Comment
  
  Mentions: acquisition stake Gilead Sciences
9. Javier Rodriguez Joins Gilead Sciences' Board of Directors
  
  Explore businesswire.com Jun 16 2020 BoardMoves
  
  ...to welcome Javier to Gilead's Board of Directors,” said Daniel O’Day, Chairman and Chief Executive Officer of Gilead Sciences. “He brings significant industry expertise and the perspective of a visionary CEO. Javier is a...
  Read Full Article
  
  Comment
  
  Mentions: Nasdaq Gilead Sciences Gilead Sciences, Inc.
10. Facebook Just Named Two Women to its Board as it Seeks Gender Parity — Here are 13 Tech Companies That Have Recently Diversified Their Boardrooms
  
  Explore Business Insider Mar 16 2020 BoardBlogs
  
  ...er Apple retail chief Angela Ahrendts to its board last May. Google parent company Alphabet brought on former Gilead Sciences executive Robin Washington last April and, in his first big move as CEO, Sundar Pichai appoint...
  Read Full Article
  
  Comment
  
  Mentions: Leadership Google Amazon
11. Corcept Therapeutics Appoints Gregg Alton to Board of Directors
  
  Explore GlobeNewswire Mar 12 2020 BoardMoves
  
  ...d psychiatric disorders by modulating the effects of the stress hormone cortisol, announced today that former Gilead Sciences executive Gregg Alton has joined Corcepts Board of Directors... ...
  Read Full Article
  
  Comment
  
  Mentions: Nasdaq Gilead Sciences Corcept Therapeutics Incorporated
12. Sandra Horning, MD To Join Moderna's Board of Directors
  
  Explore Digital Journal Feb 3 2020 BoardMoves
  
  ...ogy company focused on creating innovative medicines at lower prices, and serves on the Board of Directors of Gilead Sciences, Inc. (Nasdaq: GILD). Previously she served as Chief Medical Officer and Head of Global Produc...
  Read Full Article
  
  Comment
  
  Mentions: Investor Relations Annual Meeting Nasdaq
13. Sandra Horning, MD, Joins Gilead Sciences' Board of Directors
  
  Explore Google Jan 30 2020 BoardMoves
  
  ...Gilead Sciences, Inc. (Nasdaq: GILD) announced today that Sandra Horning, MD, has been appointed to the company's Board of Directors... . ...
  Read Full Article
  
  Comment
  
  Mentions: Nasdaq Gilead Sciences Gilead Sciences, Inc.
14. Kodiak Sciences Appoints Taiyin Yang, Ph.D., to Board of Directors
  
  Explore PR Newswire Dec 19 2019 BoardMoves
  
  ...tors. Currently, Dr. Yang serves as Executive Vice President, Pharmaceutical Development and Manufacturing at Gilead Sciences, Inc... ...
  Read Full Article
  
  Comment
  
  Mentions: Nasdaq Gilead Sciences Taiyin Yang
15. Grace Colón Succeeds Amy Abernethy on the CareDx Board
  
  Explore GlobeNewswire Jul 5 2019 BoardMoves
  
  ...She was formerly a partner at New Science Ventures and held various leadership roles at Intrexon Corporation, Gilead Sciences and Affymetrix. Earlier in her career, she was an engagement manager with McKinsey & Co. Dr. C...
  Read Full Article
  
  Comment
  
  Mentions: Investor Relations Nasdaq Executive Chairman
16. Gamida Cell Nominates Two Healthcare Industry Veterans to Its Board of Directors
  
  Explore businesswire.com Mar 21 2019 BoardMoves
  
  ...rs functions. From 2015 to 2018, Ms. Tomasello served as chief commercial officer of Kite Pharma, now part of Gilead Sciences, where she oversaw the global commercialization of Yescarta®, the first approved CAR-T therapy...
  Read Full Article
  
  Comment
  
  Mentions: Annual Meeting Nasdaq stock options
17. 1-15 of 19 1 2 »